Cogent Biosciences Inc - ESG Rating & Company Profile powered by AI
Complete Sustainability assessment of Cogent Biosciences Inc can be reached by signing up for free. If you work at Cogent Biosciences Inc and you would like to use your Sustainability rating, please contact us. This report of Cogent Biosciences Inc incorporates information from across the internet as well as from public filings by Cogent Biosciences Inc.
Cogent Biosciences Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.5; made up of an environmental score of 5.3, social score of 3.2 and governance score of 8.0.
5.5
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 602 | SkinBioTherapeutics PLC | 5.6 | High |
| 602 | XOMA Corp | 5.6 | High |
| 627 | Cogent Biosciences Inc | 5.5 | High |
| 627 | Advanced Medical Solutions Group PLC | 5.5 | High |
| 627 | Achieve Life Sciences Inc | 5.5 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Cogent Biosciences Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Cogent Biosciences Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Cogent Biosciences Inc report the average age of the workforce?
Sign up for free to unlockDoes Cogent Biosciences Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Cogent Biosciences Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Cogent Biosciences Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Cogent Biosciences Inc offer flexible work?
Sign up for free to unlockDoes Cogent Biosciences Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Cogent Biosciences Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Cogent Biosciences Inc conduct supply chain audits?
Sign up for free to unlockDoes Cogent Biosciences Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Cogent Biosciences Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Cogent Biosciences Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Cogent Biosciences Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Cogent Biosciences Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Cogent Biosciences Inc disclose water use targets?
Sign up for free to unlockDoes Cogent Biosciences Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Cogent Biosciences Inc have a product recall in the last two years?
Sign up for free to unlockDoes Cogent Biosciences Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Cogent Biosciences Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Cogent Biosciences Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Cogent Biosciences Inc disclose parental leave metrics?
Sign up for free to unlockDoes Cogent Biosciences Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Cogent Biosciences Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Cogent Biosciences Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Cogent Biosciences Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Cogent Biosciences Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Cogent Biosciences Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Cogent Biosciences Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Cogent Biosciences Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Cogent Biosciences Inc disclose its waste policy?
Sign up for free to unlockDoes Cogent Biosciences Inc report according to TCFD requirements?
Sign up for free to unlockDoes Cogent Biosciences Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Cogent Biosciences Inc disclose energy use targets?
Sign up for free to unlockDoes Cogent Biosciences Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Cogent Biosciences Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Cogent Biosciences Inc
These potential risks are based on the size, segment and geographies of the company.
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. It has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. The company was formerly known as Unum Therapeutics Inc. and changed its name to Cogent Biosciences, Inc. in October 2020. Cogent Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.